Processing your request


please wait...

Case Page

 

Case Status:    DISMISSED    
On or around 01/28/2016 (Date of order of final judgment)

Filing Date: March 19, 2015

Accelerate Diagnostics, Inc. is an in vitro diagnostics company focusing on providing solutions for antibiotic resistance and sepsis.

According to the law firm press release, the lawsuit alleges Defendants misrepresented and/or failed to disclose to investors that Accelerate Diagnostics’ main product, the ID/AST system, formally known as the BACcel system, requires a positive blood culture to diagnose pathogens in a blood sample. When the truth was revealed to investors, the price of Accelerate Diagnostics securities fell, damaging investors.

On January 28, 2016, the Court issued an Order granting Defendants' Motion to Dismiss and dismissing this action with prejudice. On February 26, Plaintiff filed a Notice of Appeal of this decision. On September 13, 2017, the Appeal was dismissed.

Protected Content


Please Log In or Sign Up for a free account to access restricted features of the Clearinghouse website, including the Advanced Search form and the full case pages.

When you sign up, you will have the option to save your search queries performed on the Advanced Search form.